Dark
Streaming/Mobile
OldĀ Site
Home
Daily
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
15:33:32 EDT Wed 22 Mar 2023
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
News for C:CYBN from 2022-03-23 to 2023-03-22 - 51 items
News Releases
In The News
Other
CA
US
Date
Sym
Company
Price
Type
Headline
2023-02-28 10:09
C
C:CYBN
Cybin Inc
0.72
News Release
200
Cybin talks data from phase 1/2A CYB003 clinical trial
2023-02-22 16:46
C
C:CYBN
Cybin Inc
0.69
News Release
200
Cybin turns attention toward efficiency, trials
2023-02-14 12:31
C
C:CYBN
Cybin Inc
0.54
News Release
200
Cybin has $20-million in cash at Feb. 14
2023-02-14 07:35
C
C:CYBN
Cybin Inc
0.54
SEDAR Interim Financial Statements
812
SEDAR Interim Financial Statements
2023-02-14 07:35
C
C:CYBN
Cybin Inc
0.54
SEDAR MD & A
815
SEDAR MD & A
2023-02-01 09:53
C
C:CYBN
Cybin Inc
0.50
News Release
200
Cybin receives OK for first-in-human dosing of CYB004
2023-01-26 10:59
C
C:CYBN
Cybin Inc
News Release
200
Cybin to hold R&D day on Feb. 28
2023-01-18 13:22
C
C:CYBN
Cybin Inc
0.60
News Release
200
Cybin details partner FS on Kernel's Flow
2023-01-12 09:53
C
C:CYBN
Cybin Inc
0.68
News Release
200
Cybin selects GAD as target indication for CYB004
2023-01-09 00:55
C
C:CYBN
Cybin Inc
0.53
News Release
200
Cybin to release CYB003 interim readout by end of Feb.
2022-12-20 10:46
C
C:CYBN
Cybin Inc
0.38
News Release
200
Cybin summarizes 2022 operations
2022-12-06 16:45
C
C:CYBN
Cybin Inc
0.44
News Release
200
Cybin presents CYB003 preclincical data at ACNP
2022-11-14 22:09
C
C:CYBN
Cybin Inc
0.59
SEDAR Interim Financial Statements
812
SEDAR Interim Financial Statements
2022-11-14 22:09
C
C:CYBN
Cybin Inc
0.59
SEDAR MD & A
815
SEDAR MD & A
2022-11-14 18:26
C
C:CYBN
Cybin Inc
0.59
News Release
200
Cybin has cash of $29.9-million on Sept. 30
2022-11-10 17:15
C
C:CYBN
Cybin Inc
0.57
News Release
200
Cybin completes dosing of four cohorts in phase 1 trial
2022-10-27 13:42
C
C:CYBN
Cybin Inc
0.63
News Release
200
Cybin facilitators graduate from Embark program
2022-10-11 00:16
C
C:CYBN
Cybin Inc
0.82
News Release
200
Cybin recognizes World Mental Health Day
2022-10-06 14:33
C
C:CYBN
Cybin Inc
0.85
News Release
200
Cybin talks patent filings
2022-09-27 11:45
C
C:CYBN
Cybin Inc
0.72
News Release
200
Mindset licenses IP for preclinical compounds to Cybin
2022-09-20 15:36
C
C:CYBN
Cybin Inc
0.86
News Release
200
Cybin achieves R&D milestones ahead of schedule
2022-08-31 09:47
C
C:CYBN
Cybin Inc
1.41
News Release
200
Cybin's Adelia achieves final milestone of 2020 deal
2022-08-30 09:44
C
C:CYBN
Cybin Inc
1.41
News Release
200
Cybin doses two patients in phase 1/2a psilocybin trial
2022-08-17 09:08
C
C:CYBN
Cybin Inc
1.01
News Release
200
Cybin receives DEA licence for phase 1/2a CYB003 trial
2022-08-15 18:16
C
C:CYBN
Cybin Inc
0.97
News Release
200
Cybin shareholders elect six directors at AGM
2022-08-09 15:16
C
C:CYBN
Cybin Inc
0.92
Prospectus Approved
3
Cybin to list additional shares
2022-08-08 18:09
C
C:CYBN
Cybin Inc
0.92
SEDAR Interim Financial Statements
812
SEDAR Interim Financial Statements
2022-08-08 18:09
C
C:CYBN
Cybin Inc
0.92
SEDAR MD & A
815
SEDAR MD & A
2022-08-08 17:49
C
C:CYBN
Cybin Inc
0.92
News Release
200
Cybin arranges $35-million (U.S.) equity program
2022-08-08 17:35
C
C:CYBN
Cybin Inc
News Release
200
Cybin ends Q1 with cash of $42.5-million
2022-07-11 11:26
C
C:CYBN
Cybin Inc
0.73
News Release
200
Cybin completes acquisition of DMT study from Entheon
2022-06-27 19:38
C
C:CYBN
Cybin Inc
0.77
News Release
200
Cybin unit Adelia reaches Y2, Q3 (i), milestone
2022-06-27 10:15
C
C:CYBN
Cybin Inc
0.74
News Release
200
Cybin receives IND OK for phase 1/2a CYB003 trial
2022-06-22 12:52
C
C:CYBN
Cybin Inc
0.70
News Release
200
Cybin has cash position of $53.6-million at March 31
2022-06-22 07:27
C
C:CYBN
Cybin Inc
0.70
SEDAR Annual Information Form
802
SEDAR Annual Information Form
2022-06-22 07:27
C
C:CYBN
Cybin Inc
0.70
SEDAR Audited Annual Financial Statements
804
SEDAR Audited Annual Financial Statements
2022-06-22 07:22
C
C:CYBN
Cybin Inc
0.70
SEDAR MD & A
815
SEDAR MD & A
2022-06-09 18:09
C
C:CYBN
Cybin Inc
0.78
News Release
200
Cybin to begin phase 1/2a clinical trial for CYB003
2022-06-07 11:17
C
C:CYBN
Cybin Inc
0.95
News Release
200
Cybin to acquire DMT study from Entheon for $1M
2022-06-03 18:27
C
C:CYBN
Cybin Inc
0.98
News Release
200
Cybin subsidiary Adelia hits $2.03M worth of milestones
2022-06-03 10:43
C
C:CYBN
Cybin Inc
0.95
News Release
200
Cybin develops Embark training program team
2022-06-02 16:16
C
C:CYBN
Cybin Inc
0.95
News Release
200
Cybin publishes peer-reviewed article about Embark
2022-05-31 10:05
C
C:CYBN
Cybin Inc
0.86
News Release
200
Cybin submits IND application to FDA for CYB003 trial
2022-04-21 10:10
C
C:CYBN
Cybin Inc
0.93
News Release
200
Cybin contracts Clinilabs for CYB003 phase 1/2a trial
2022-04-13 09:56
C
C:CYBN
Cybin Inc
0.93
News Release
200
Cybin talks up results of CYB004 inhalation study
2022-04-08 09:50
C
C:CYBN
Cybin Inc
0.96
News Release
200
Cybin applauds WIPO patent application for psychedelics
2022-04-01 10:18
C
C:CYBN
Cybin Inc
1.02
News Release
200
Cybin's Adelia meets contribution milestone
2022-03-31 14:25
C
C:CYBN
Cybin Inc
1.02
News Release
200
Cybin begins Kernel Flow feasibility study
2022-03-29 12:06
C
C:CYBN
Cybin Inc
0.97
News Release
200
Cybin's CYB003 "well tolerated" in preclinical studies
2022-03-25 11:00
C
C:CYBN
Cybin Inc
0.94
News Release
200
Cybin's Adelia meets contribution milestones
2022-03-24 13:04
C
C:CYBN
Cybin Inc
0.95
News Release
200
Cybin seeks participants for Kernel feasibility study